PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
A C-->G nucleotide transition in exon 4 of PTPRC (encoding protein-tyrosine phosphatase receptor-type C, also known as CD45) was recently reported to be genetically associated with the development of multiple sclerosis (MS). We performed an extensive evaluation of this polymorphism using large family-based and case-control comparisons. Overall, we observed no evidence of genetic association between the PTPRC polymorphism and MS susceptibility or disease course.
Barcellos
L F
LF
Department of Neurology, University of California at San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.
Caillier
S
S
Dragone
L
L
Elder
M
M
Vittinghoff
E
E
Bucher
P
P
Lincoln
R R
RR
Pericak-Vance
M
M
Haines
J L
JL
Weiss
A
A
Hauser
S L
SL
Oksenberg
J R
JR
D000328:Adult; D016022:Case-Control Studies; D002878:Chromosomes, Human, Pair 1; D005091:Exons; D005260:Female; D006801:Humans; D017493:Leukocyte Common Antigens / Q000235:genetics*; D008297:Male; D009103:Multiple Sclerosis / Q000235:genetics*; D017354:Point Mutation; D011110:Polymorphism, Genetic; D014481:United States
D017493:Leukocyte Common Antigens